KROUZON
Restoring Normal Child Development Without Lifelong Surgeries
About Krouzon
Krouzon Pharmaceuticals was founded by Dr. V.P. Eswarakumar, a then Associate Professor at Yale University, after 25+ years of hands-on research experience. He created the world’s first disease model for Crouzon and Pfeiffer syndromes and discovered treatment methods.
At Krouzon
Krouzon is developing therapeutics for children born with FGFR2-related Craniosynostosis Syndromes
Meet The Team
-
V.P. Eswarakumar, Ph.D.
-
Research & Development Team
-
Management Team